Accord Healthcare, Inc. is recalling 33,629 bottles of Levothyroxine Sodium Tablets, USP, because the medication is subpotent. Subpotency means the tablets contain less than the required amount of active ingredient (levothyroxine sodium), which may affect how well the medication works. The recall includes four different strengths of the medication (25 mcg, 50 mcg, 88 mcg, and 112 mcg) sold in 90-count or 1000-count bottles.
Taking subpotent thyroid medication can lead to inadequate treatment of hypothyroidism, potentially causing symptoms like fatigue, weight gain, depression, and sensitivity to cold to return or worsen. No specific reports of injuries or adverse events were mentioned in the recall data.
You have 2 options:
1000 count bottles; Manufactured by Intas Pharmaceuticals Limited.
1000 count bottles; Manufactured by Intas Pharmaceuticals Limited.
1000 count bottles; Manufactured by Intas Pharmaceuticals Limited.
90 count bottles; Manufactured by Intas Pharmaceuticals Limited.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.